FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to using herbal products, to medicine and pharmacology, namely to reduce the mutagenic effect of the anti-drug preparation. What is presented is the use of miliacin as an agent which reduces the mutagenic effect of cyclophosphan.
EFFECT: invention provides limiting by-effects of chemotherapy.
1 cl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR REDUCING SYSTEMIC PATHOLOGIC ENDOTOXINEMIA | 2014 |
|
RU2564918C1 |
AGENT LIMITING LYMPHOTOXIN EFFECT OF METHOTREXATE | 2007 |
|
RU2337693C1 |
METHOD OF PROTECTING POST-VACCINATION IMMUNITY TO TETANUS ANATOXIN AGAINST METHOTREXATE-INDUCED DEPRESSION | 2008 |
|
RU2394577C1 |
METHOD FOR PREVENTION AND CORRECTION OF CYTOGENETIC DISORDER | 2012 |
|
RU2504392C1 |
ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
METHOD FOR ANTIMUTAGENIC EFFECT ON BODY | 2003 |
|
RU2261704C2 |
METHOD FOR REDUCING GEMOTOXIC ACTION OF BENZENE ON AN ORGANISM | 2017 |
|
RU2724891C2 |
MEDICATION INCREASING ANTITUMOUR EFFECT OF METHOTREXATE | 2009 |
|
RU2411947C1 |
AGENT ENHANCING IMMUNOGENIC PROPERTY OF TETANUS ANATOXIN | 2003 |
|
RU2244548C1 |
METHOD FOR COMPLEX CORRECTION OF NON-SCARRING ALOPECIA IN EXPERIMENT | 2023 |
|
RU2821779C1 |
Authors
Dates
2019-08-23—Published
2019-04-17—Filed